Novonesis (Novozymes) A/S risk profile
47 Elevated one input has moved against it
Measured 1 September 2026 from NSIS-B's filed statements. Recomputed nightly.
47 (Elevated), driven by Competitive position at 60, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 20 | Normal | Stable | One-year price volatility — 27.5% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 16 | Contained | Stable | Capital spending against operating cash — 0.34x |
| Leverage and coverage | Reads total_debt, cash_and_cash_equivalents, ebitda, interest_expense, total_current_assets, total_current_liabilities and a disclosed CET1 ratio, for a bank or insurer. No reading is stored for this company. | |||
| Competitive position | 60 | Stretched | Stable | Revenue-growth gap against peers — -83.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Basic Materials companies with a risk reading
BHP Group Ltd 22Linde Plc. 36Industria De Diseno Textil SA 28Southern Copper Corporation 15Rio Tinto Group 42Rio Tinto plc 42Newmont Corp 12Freeport-McMoRan Inc 38Agnico Eagle Mines Ltd 9Glencore plc 61Sherwin-Williams Company 45Ecolab Inc 39
Financials, valuation and price history for Novonesis (Novozymes) A/S